Last reviewed · How we verify
A Phase II Study of ORZEL (UFT + Leucovorin) in Elderly (at Least 75 Years Old) Patients With Colorectal Cancer
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of fluorouracil-uracil and leucovorin in treating elderly patients who have metastatic colorectal cancer.
Details
| Lead sponsor | Eastern Cooperative Oncology Group |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Start date | 2000-10-09 |
Conditions
- Colorectal Cancer
Interventions
- leucovorin calcium
- tegafur-uracil
Countries
United States, Puerto Rico